Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer

C Teng, J Cohen, S Egger, PL Blinman… - Supportive Care in …, 2022 - Springer
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …
被引用次数：43 相关文章

Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.

C Teng, J Cohen, S Egger, PL Blinman… - Supportive Care in …, 2021 - europepmc.org
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …

Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer

C Teng - 2022 - centralcoast.intersearch.com.au
PURPOSE: Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …

Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.

C Teng, J Cohen, S Egger, PL Blinman… - Supportive Care in …, 2022 - go.gale.com
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …

Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer

C Teng - 2022 - elibrary.cclhd.health.nsw.gov.au
PURPOSE: Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …

Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer

C Teng, J Cohen, S Egger… - Supportive Care in …, 2022 - search.proquest.com
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …
[PDF] researchgate.net

[PDF][PDF] Systematic review of long‑term chemotherapy‑induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer

C Teng, J Cohen, S Egger, PL Blinman… - Supportive Care in …, 2022 - researchgate.net
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …

Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer

C Teng, J Cohen, S Egger… - Supportive care in …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …

Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.

C Teng, J Cohen, S Egger… - Supportive Care in …, 2022 - search.ebscohost.com
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) is the most common dose-
limiting side effect of oxaliplatin. It often persists and can adversely affect quality of life of …